Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Fig. 4 | Journal of Inflammation

Fig. 4

From: Sodium butyrate alleviates R97-116 peptide-induced myasthenia gravis in mice by improving the gut microbiota and modulating immune response

Fig. 4

Effects of sodium butyrate on Tfh and B cell frequency and the representative cytokines and IgG antibodies levels. Mononuclear cells (MNCs) of the spleens were isolated from mice in three groups on day 70. A Tfh cells and (C) B cells were detected by flow cytometry. B The percentages of Tfh and D B cells in MNCs were calculated (n = 3 mice/group). Levels of E IFN-γ, F IL-17 A, G IL-10, H IL-21, and I titer of IgG antibody in the blood were measured by ELISA (n = 6 mice/group). Data were from three independent experiments and expressed as mean ± SEM. The significance of differences was assessed by ANOVA, followed by Tukey’s testing as a post-hoc test. ns means not significant, *p < 0.05, **p < 0.01, and ***p < 0.001

Back to article page

Journal of Inflammation

ISSN: 1476-9255

Contact us